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ABSTRACT
Much effort has long been devoted to unraveling
the coordinated cellular response to genotoxic
insults. In view of the difficulty of obtaining human
biological samples of homogeneous origin, I have
established a set of stable human clones where one
DNA repair gene has been stably silenced by means
of RNA interference. I used pEBVsiRNA plasmids
that greatly enhance long-term gene silencing in
human cells. My older clones reached 4500 days
in culture. Knock-down HeLa clones maintained a
gene silencing phenotype for an extended period in
culture, demonstrating that I was able to mimic cells
from cancer-prone syndromes. I have silenced 420
genes acting as sensors/transducers (ATM, ATR,
Rad50, NBS1, MRE11, PARG and KIN17), or
of different DNA repair pathways. In HeLa cells,
I have switched off the expression of genes involved
in nucleotide excision repair (XPA, XPC, hHR23A,
hHR23B, CSA and CSB), nonhomologous
end-joining (DNA-PKcs, XRCC4 and Ligase IV),
homologous recombination repair (Rad51 and
Rad54), or base excision repair (Ogg1 and
Ligase III). These cells displayed the expected DNA
repair phenotype. We could envisage untangling the
complex network between the different DNA
repair pathways. In this study, no viral vehicles,
with their attendant ethical and safety concerns,
were used.
INTRODUCTION
A large body of evidence demonstrates that impaired
responses to genotoxic insults are involved in cancer
development. After a DNA insult, a coordinated cellular
response takes place, including damage recognition,
signal-transduction pathways (with both sensor and
transducer proteins) and the response to the
DNA damage per se (cell cycle checkpoints, DNA
repair and apoptosis) (1). These interwoven responses
insure genome integrity. As a consequence, mutations
in genes encoding proteins involved in the main DNA
repair pathways, such as nucleotide excision repair
(NER), translesion synthesis (TLS), mismatch repair
(MMR), nonhomologous end-joining (NHEJ) or
base excision repair (BER) may cause chromosome
and genetic instability, telomere defects and cancer
predisposition (2–5).
Fewer than 20 DNA repair disorders have been
identiﬁed so far. Besides the well-known xeroderma
pigmentosum (XP), Cockayne’s syndrome (CS) and
trichothiodystrophy (TTD) syndromes, which aﬀect the
two branches of the NER pathway (global genome repair
versus transcription-coupled repair), mutations in other
DNA repair pathways have also been identiﬁed.
For instance, mutations in some components of the
NHEJ have been observed for ligase IV (LIG4 syndrome),
Artemis (RS-SCID, human radiosensitive severe
combined immunodeﬁciency syndrome), DNA-PKcs
(M059J glioblastoma cells) and Cernunnos (6). Also,
chromosomal instability associated with impaired RecQ
helicase functions is associated with Bloom syndrome (BS
protein), Werner syndrome (WS; WR protein) and
Rothmund–Thompson syndrome (RTS) (7–9).
Mutations are also found in diﬀerent proteins that act as
sensor proteins for DNA lesions and/or chromatin
alterations, or transducer proteins for conveying the
damage signal to downstream eﬀector proteins. These
hereditary mutations have been found in several
syndromes and diseases, such as the Li-Fraumeni syn-
drome (p53 gene), ataxia-telangiectasia (AT; ATM gene),
ATR-Seckel syndrome (ATR; ATR gene), AT-like disease
(ATLD, MRE11 gene), Nijmegen breakage syndrome
(NBS, NBS1 gene) and Fanconi anemia (FA).
It turns out that cells arising from these patients
represent the major source of DNA repair-deﬁcient
human cells (10). However, the major limitation is the
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As a consequence, to study the relationship between the
main DNA repair pathways I envisaged establishing a set
of isogenic human cell lines in which one speciﬁc gene
is silenced by the RNA interference method. Because
RNAi is an endogenous natural pathway, its power as a
gene-silencing tool is greater than that of other
approaches.
Most studies describing RNA interference in cultured
human cells are based on transient transfections of
siRNA duplexes or plasmids, or transient infection of
virus-expressing siRNA constructs. In the strategy based
on siRNA-expressing plasmids, use is made of integrative
plasmids that could lose their siRNA cassette during
selection pressure. An elevated number of siRNA-based
plasmids per cell or an elevated viral titer may saturate
the RNAi machinery (RISC). As a consequence,
overexpression of siRNA through either siRNA duplexes
or integrative vectors may lead to mistaken conclusions in
transient experiments. Hence, long-term maintenance of
gene silencing is riddled with pitfalls.
To overcome these shortcomings, I have designed
episomal plasmids driving the in cellulo siRNA synthesis.
I have harnessed the eﬃciency of the siRNA approach
with Epstein–Barr virus (EBV)-derived vectors in order to
establish cell lines carrying a few plasmid copies per cell.
For many years, pEBV-based plasmids have been used to
eﬃciently modify human cell genotypes (11,12). These
plasmids bear the latent replication origin of the
EBV virus (OriP) and allow the expression of only
one viral protein, EBV nuclear antigen-1 (EBNA-1).
The main features of these vectors have been recently
reviewed (13). EBNA-1 tethers EBV episomes to
metaphase chromosomes, providing the basis for their
nuclear retention and their successful segregation at
mitosis (14,15). Interestingly, the presence of EBNA-1
does not interfere with the diﬀerentiation of human
cells (16). EBV DNA replication is semi-conservative
and is coordinated with genomic replication (17–19).
OriP appears to be regulated like human endogenous
DNA replication. Since these vectors behave like
endogenous transcription units, it was expected that they
would tightly regulate siRNA expression over a long
period of time.
So far, I have developed and characterized 4200
replicative pEBVsiRNA plasmids for their ability to
impose eﬃcient, speciﬁc and very long-term gene silencing
in diﬀerent human cell lines. In terms of DNA repair, my
main aim was to establish a set of isogenic cell lines in
which the expression of one speciﬁc DNA repair gene is
abrogated. Here 440 genes were targeted, and my older
clones reached 4500 days in culture. These older clones
maintained impressive gene silencing. This approach
allows us to validate the choice of an eﬃcient siRNA
sequence that remains eﬃcient in cells even several
months following transfection. This also aﬀords us the
opportunity to compare short- and long-term eﬀects of
RNAi. Here, I present new clones that will help us to
untangle the relationships between the diﬀerent DNA
repair pathways.
MATERIALS AND METHODS
Design ofpEBVsiRNA vectors
The crucial step in RNAi is the unfailing recognition of
the cognate mRNA by the siRNA sequence. Since Tuschl
and colleagues described the initial design paradigm for
eﬃcient 21nt siRNA (20,21), many rational designs have
been developed, based on a better understanding of RNAi
biochemistry (22,23). I adopted the algorithm developed
by Sonnhammer and collaborators (24). All my siRNA
sequences targeted the open reading frame of a speciﬁc
gene.
Cloning was performed using my pEBVsiRNA-LacZ’
vectors carrying either a hygromycin B or puromycin
resistance cassette (pBD751 and pBD899, respectively) (13).
These vectors carry the H1 RNA polymerase III promoter
(RNA pol III) to drive the transcription of short hairpin
RNA (shRNA), which gives rise to siRNA-like molecules
in vivo. These cloning plasmids allow blue/white screening
of bacterial colonies carrying a recombinant pEBVsiRNA
plasmid with the DNA coding for a shRNA sequence.
Hence, shRNA cloning reaches 100% eﬃciency, thus
reducing the time of selection and characterization of
recombinant plasmids. For each gene, 2–4 vectors were
assessed for both short- and long-term silencing (several
months). In each case, I selected the best vector according
to three criteria: (i) highly eﬃcient silencing of the gene
of interest, (ii) maintenance of this gene silencing over
time and (iii) accuracy of the expected phenotype
(loss-of-function) when this phenotype is known.
Cell culture, treatment and flowcytometry
HeLa (cervical adenocarcinoma) cells were maintained in
Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Invitrogen, Carlsbad, CA, USA) supplemented with
10% fetal calf serum (FCS), 100U/ml penicillin and
100mg/ml streptomycin, under 5% CO2. HeLa cells were
transfected using 2ml of LipofectAMINE2000
(Invitrogen) with 2mg of DNA. Transfected cells were
propagated in culture in the presence of hygromycin B
(125mg/ml; Invitrogen). After transfection of HeLa cells,
12 clones per gene were propagated in culture, and
growing clones were analyzed for loss-of-function.
Thereafter, only one clone was selected and added to my
battery of knock-down clones (other clones being frozen).
Among the 40 genes targeted, 20 are listed in Table 1. The
other targeted genes have also been successfully silenced
for a long period in culture, and the new knock-down
clones have to be further characterized (data not shown).
Among them, I have targeted the PARP2, PARG,
BRCA1, ERCC1, XRCC1, TRF2 or cdc25b genes.
For clonogenic growth, only established long-term
clones were used. Cells were plated at 500 cells per
6-cm-diameter dish 24h before treatments. Growing
clones were ﬁxed with 4% paraformaldehyde, and stained
with methylene blue (in 30% methanol) after 14 days of
culture. Clones containing 450 cells were counted. Each
point represents the mean of three culture dishes.
Experiments were performed at least twice. Colony
formation was normalized as a percentage of the control.
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clones were seeded per 6-cm-diameter dish 2 days before
treatments. Cells were treated with UVC 10J/m
2, g rays
6Gy(
137Cs g-ray source; dose rate of 1.9Gy/min; IBL 637
CisBio International, Bedford, MA, USA) or etoposide
(Ve ´ pe ´ side-Sandoz; 25mM for 1.5h) and harvested
24h later. Flow cytometry analysis was described
elsewhere (25). Brieﬂy, adherent cells were collected by
trypsinization, washed with PBS and ﬁxed in 75% ethanol
at 48C for at least 24h. Cells were washed twice in PBS
and nuclear DNA was stained with propidium iodide
(Sigma, St. Louis, MO, USA; 4mg/ml) in the presence of
RNase (Sigma; 10mg/ml) in PBS for at least 30min.
Stained cells were analyzed on a FACScalibur (Becton
Dickinson, Franklin Lakes, NJ, USA) using CellQuest
software. Here,  10000 cells gated as single cells using
FL2A/FL2W scatter were analyzed.
Western blot,immunostaining andin vitro NHEJ assay
Procedures were described elsewhere (26). For in vitro
NHEJ, whole-cell extracts and DNA substrates were
prepared as described elsewhere (27–29).
RESULTS
Silencing ofgenesof the NER pathway
I targeted genes of the main pre- and post-replicative
DNA repair pathways. Preliminary experiments were
performed to silence the XPA and XPC genes in order
to circumvent the transcription-coupled (TC) and global
genome (GG) NER pathways. XPA is involved in
both TC- and GG-NER pathways and XPC is only
required for GG-NER. Numerous knock-down clones
were characterized, and all of them displayed very low or
nearly undetectable amounts of either XPA or
XPC protein (Figure 1). Several XPA
KD and XPC
KD
clones have been recently described in detail (25,29).
As expected, XPA
KD and XPC
KD clones exhibited an
‘XP’ phenotype with great sensitivity to UVC and an
impaired unscheduled DNA repair synthesis (UDS) after
UVC irradiation (25). Strikingly, in HeLa or MCF-7 cells,
XPC
KD cells displayed major growth disadvantages in
comparison with their XPA
KD counterparts. This could
be correlated with the critical interactions of XPC
(C-terminal portion) with hHRad23B, centrin 2 or
TFIIH (30).
I have now enlarged this approach by focusing on
two other genes tightly associated with the XPC pathway,
hHR23A and hHR23B. Two interpretations have been
proposed: (i) hHR23A&B may stabilize the XPC protein
by protecting it from 26S proteasome-dependent protein
degradation (31), and (ii) hHR23B may be a key event
in the displacement of XPC from damaged DNA by
the XPA–RPA complex (32). I found that hHR23B
knock-down dramatically hampered HeLa cell growth,
as did XPC gene silencing. In contrast, the shutting down
of the hHR23A gene expression did not signiﬁcantly aﬀect
cell growth (data not shown).
I also focused my attention on the CSA and CSB
genes (Cockayne’s syndrome genes). Figure 2 shows
the remaining CSB protein content observed in two
CSB
KD HeLa clones 120 days after transfection. The
human CSB (rad26 homolog) belongs to a large complex
that transiently interacts with the transcription machinery
to check whether RNA synthesis occurs faithfully
(for review 33). As a SWI/SNF chromatin-remodeling
factor, CSB aﬀects the chromatin conformation of both
Table 1. Eﬃcient pEBVsiRNA vectors for long-term silencing
Protein pEBVsiRNA plasmid siRNA sequence Position (nt)
1 XPC (Q01831) pBD634 (pEBVsiXPC-267) 50-GGATGAAGCCCTCAGCGAT-30 267–285
2 XPA (P23025) pBD695 (pEBVsiXPA-587) 50-GTCAAGAAGCATTAGAAGA-30 587–605
3 XRCC4 (Q13426) pBD694 (pEBVsiXRCC4-674) 50-GAGATCCAGTCTATGATGA-30 674–692
4 DNA-PKcs (P78527) pBD743 (pEBVsiDNAPK-5980) 50-GTTGAGGTTCCTATGGAAA-30 5980–5998
5 Rad50 (Q92878) pBD872 (pEBVsiRad50-274) 50-GAACTTATAGCTGTGCAAA-30 274–292
6 MRE11A (P49959) pBD930 (pEBVsiMRE11-464) 50-GTTCAATGTCTGTGGAGAA-30 464–482
7 NBS1 (O60934) pBD932 (pEBVsiNBS1-160) 50-GTAACCAACCTGAGTCAAA-30 160–178
8 Rad51 (Q06609) pBD864 (pEBVsiRad51-114) 50-GAAGAAATTGGAAGAAGCT-30 114–132
9 Rad54 (Q92698) pBD912 (pEBVsiRad54-987) 50-GAATGATCTGCTTGAGTAT-30 987–1005
10 hHR23A (P54725) pBD805 (pEBVsiR23A-491) 50-AGACGATGCTGACGGAGAT-30 491–509
11 hHR23B (P54727) pBD804 (pEBVsiR23B-1123) 50-GCATTAGGATTTCCTGAAG-30 1123–1141
12 ATM (Q13315) pBD935 (pEBVsiATM-2594) 50-GTGTTAGTGATGCAAACGA-30 2594–2612
13 ATR (Q13535) pBD962 (pEBVsiATR-854) 50-CTGACCAATTGAAACTCTA-30 854–872
14 CSA (Q13216) pBD918 (pEBVsiCSA-191) 50-CAGATGGTGTGATTGTACT-30 191–209
15 CSB (Q03468) pBD921 (pEBVsiCSB-1358) 50-GAGATGATGGAGATGAAGA-30 1358–1376
16 Ligase III (P49916) pBD941 (pEBVsiLigIII-164) 50-GCATGTTTGAGAAACTAGA-30 164–182
17 Ligase IV (P49917) pBD940 (pEBVsiLigIV-1939) 50-CCTAACCTTACTAACGTTA-30 1939–1957
18 Ogg1 (O15527) pBD784 (pEBVsiOgg1-177) 50-AGCGGATCAAGTATGGACA-30 177–195
19 Kin17 (O60870) pBD674 (pEBVsiK180) 50-TCCTCAGCAGTTTATGGAT-30 180–198
20 PARG (Q86W56) pBD813 (pEBVsiPARG-2325) 50-GGATCACAATGAATGTCTA-30 2325–2343
21 Ku70 (P12956) pBD699 (pEBVsiKu70-156R) 50-GAGTGAAGATGAGTTGACA-30 156–174
For each gene, 2–4 vectors were constructed. Puromycin plasmids were systematically constructed for all genes tested in order to allow the
establishment of double knock-down cells. The siRNA sequence and its position in the ORF are indicated (with ATG as the ﬁrst nucleotide). It is
noteworthy that only Ku70 gene silencing leads to cell death after  10 days of culture.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3537active genes and those found throughout the genome.
CSB participates in TC-NER in human cells, but
presumably in other DNA repair mechanisms too,
because it was found tightly associated with other DNA
repair proteins, such as Ogg1 and PARP1. While CSA and
CSB nullizygous mice are not viable (34), I found that all
isolated CSA
KD and CSB
KD cells maintained a residual
amount of the targeted protein, suggesting that these
proteins could be essential for cell survival in the absence
of genotoxic injuries.
Silencing of genesof other DNA repair pathways
(e.g.NHEJ versus HR)
The repair of DNA double-strand breaks (DSBs) is critical
for the maintenance of genomic stability. In eukaryotes,
two pathways deal with such DNA lesions to ensure
faithful DNA repair: the NHEJ and the homologous
recombination (HR) pathways. Although NHEJ can
function throughout the cell cycle, it predominates in G0
and G1 phases. In contrast, HR acts in S and G2 phases.
The NHEJ pathway includes at least seven factors:
Ku70, Ku80, DNA-PK(cs), Artemis, Xrcc4 and
DNA ligase IV (Lig IV), and recently Cernunnos (6).
The Ku70–Ku80 heterodimer binds to DNA ends
and recruits the PI-3K-like kinase DNA-PKcs (catalytic
subunit of the DNA-dependent protein kinase).
DNA-PKcs phosphorylates, associates with, and activates
the Artemis endonuclease, which is required to resolve
DNA hairpin structures. One of the targets of DNA-PKcs
is the XRCC4 protein, which associates with
DNA-Lig IV. The XRCC4/Lig IV complex is responsible
for the ﬁnal ligation step (for review 35). To impair the
NHEJ pathway, I targeted Ku70, XRCC4, DNA-PKcs
and Lig IV.
All attempts to silence the Ku70 gene with diﬀerent
vectors (e.g. pBD699 plasmid; Figure 2C) led to cell death
after  15 days of culture (in the presence of hygromycin B),
further indicating that the Ku70 protein is an essential
factor in human cells. This contrasts with Ku70 knock-out
mice, which are viable, but display severe defects in
DSBR, growth and B cell development (for review 34).
In contrast, I successfully established XRCC4
KD
(pBD694), DNA-PKcs
KD (pBD743) and more recently
Lig IV
KD (pBD940) cells for a very long period of time.
The protein content of knock-down HeLa clones was
monitored constantly, as shown in Figures 2 and 3. The
establishment of XRCC4
KD and DNA-PKcs
KD clones
demonstrates that the cells were sensitive to ionizing
radiation and DSB-inducing agents. The marked
reduction in either XRCC4 or DNA-PKcs protein levels
triggers a failure in DSB rejoining activity, as shown by an
in vitro NHEJ assay. In vitro NHEJ activities were
DAPI XPC DAPI XPA
XPAKD
(day 143) 
XPCKD 
(day 226)
Control
Figure 1. Immunocytochemical staining of knock-down HeLa clones. Long-term silenced clones were propagated in culture and analyzed (one
representative ﬁeld is shown for each clone; Magniﬁcation  100).
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substrates (29). In these conditions, NHEJ activities were
reduced by 70–80% in DNA-PKcs
KD and XRCC4
KD
cells, depending on DNA end conﬁguration after cutting
with diﬀerent restriction enzymes: cohesive ends,
blunt ends, 30 end/30 end, 50 end/blunt end, 30 end/blunt,
50 end/30 end (Figure 3). As controls, KIN17
KD clones
were used. This study indicated that the reduction in the
XRCC4 protein level abrogated the re-circularization of
diﬀerent linear substrates, suggesting that XRCC4 is a
limiting factor in NHEJ. The establishment of XRCC4
KD
HeLa clones is interesting because no human cell line
lacking this protein has been identiﬁed to date. Only
Artemis, Lig IV and Cernunnos are known V(D)J/NHEJ
factors deﬁcient in human heritable diseases. In parallel to
DNA-PKcs
KD and XRCC4
KD, I have recently isolated
diﬀerent Lig IV
KD clones (Figure 2). We observed that Lig
IV deﬁciency lowered in vitro NHEJ activities to a lesser
extent than did DNA-PKcs
KD and XRCC4
KD (data not
shown). My stable knock-down clones may allow us to
answer numerous exciting questions. For instance, there
are at least two NHEJ complementary sub-pathways with
diﬀerent kinetics, the high-speed classical D-NHEJ
(strictly dependent on DNA-PK and XRCC4 protein)
and a low-speed B-NHEJ (Backup; also termed
microhomology-based end-joining pathway). These two
sub-pathways seem to contribute to the major rescue
of IR-induced DSBs in higher eukaryotes (36,37).
It appeared that in vitro NHEJ activity was tightly
dependent on both XRCC4 and DNA-PKcs proteins.
Beside, XRCC4 protein may be a limiting factor in NHEJ,
but not DNA-PKcs, because XRCC4
KD cells displayed no
detectable re-circularization activity (‘OC’ and ‘CC’
products). On the other hand, most of the building
blocks of B-NHEJ are unknown; DNA ligase III (Lig III)
has been identiﬁed as one (38). Lig III participates in the
last step of the BER pathway by sealing the remaining
single-strand break. Lig III is stabilized in vivo by its
tight interaction with XRCC1 (for review 39). I have
now established diﬀerent Lig III
KD clones (two clones are
depicted in Figure 2A, lanes 1 and 2) that will allow us
to investigate this issue. Interestingly, Lig III
KD cells
were easily obtained with a nearly undetectable protein
level, as shown by western blot and immunocytochemical
staining. Furthermore, a cell population continues
to maintain an undetectable Lig III protein level 40 days
after transfection, strongly suggesting that the loss of
this protein did not alter the viability and growth of
HeLa cells in the absence of genotoxic injuries (Figure 2A,
lane 3).
1. LigIIIKD cl.6 (day40)
2. LigIIIKD cl.11 (day40)
3. LigIIIKD population (day40)
4. CSBKD cl.21 (day120)
5. CSBKD cl.22 (day120)
12 3 45
wb548
CSB 
LigIII
NBS1
PCNA 
LigIV
A
C
B
D
LigIIIKD cl. 6
(day 36)
Control 
(BD650)
DAPI LigIII
06bd 464 06bd 464
06bd 469 06bd 469
06bd 472 06bd 472 LigIIIKD cl. 11
(day 36)
CSBKD cl. 22 
(day 119)
CSBKD cl. 21
(day 119)
DAPI CSB
06bd 483 06bd 483
06bd 480 06bd 480
06bd 477 06bd 477 Control 
(BD650)
1. DNA-PKcsKD cl. 1 (day227)
2. Ku70KD (day5) 
3. XRCC4KD cl.9 (day206)
4. LigIVKD cl. 1 (day40) 
5. LigIVKD cl. 3 (day40)
6. LigIVKD cl. 6 (day40)
7. LigIVKD cl. 7 (day40)
8. LigIVKD cl. 10 (day40)
9. LigIVKD cl. 12 (day40
wb549
1 2 3 456789
PCNA
XRCC4
Ku70
NBS1
LigIV
Figure 2. Protein analysis of long-term LigIII
KD, LigIV
KD, XRCC4
KD and CSB
KD clones.
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epistasis group, such as Rad51, Rad52 and Rad54, in
order to abrogate a part of HR activity. Here, I present
results from Rad51
KD and Rad54
KD clones. Rad51 gene
silencing induced cell death and few clones with a reduced
Rad51 protein level could be expanded in mass culture.
Preliminary observations indicate that Rad51
KD cells
display an expected phenotype, as discussed below
(Figures 5 and 6).
Silencing of thecomponent of theMRN complex
Another interesting ﬁeld of investigation is the sensor/
transducer pathway, which is critical for genomic stability.
The MRN complex (MRE11, Rad50 and NBS1) plays an
essential role in the intracellular signaling pathway
activated after DNA damage, in particular in the cellular
response to stalled replication forks. MRN acts as a DNA
damage sensor, continuously localized at sites of unre-
paired DNA damage. MRN also participates in other
essential mechanisms, such as DNA replication, cell cycle
checkpoints and telomere maintenance. Nbs1 binds to
gH2AX in the vicinity of DSBs, and recruits Rad50 and
Mre11. While Mre11 has both nuclease and DNA-
unwinding activities, Rad50 adopts a ‘V-like’ conforma-
tion to act as a bridge to hold together the broken ends of
DSBs and prevent extensive degradation of the DNA
 
06 bd356 0 6bd35 6
06 bd340 0 6bd34 0
0 6bd3 14 06bd 314
06 bd301 06b d301
 
06 bd356 0 6bd35 6
06 bd340 0 6bd34 0
0 6bd3 14 06bd 314
06 bd301 06b d301
A
BC
Ku80/Ku70
XRCC4
DNA-PKcs
Ligase IV
XPC
1    2 3
sb60 4h 030605
1 2 3 4 5     6
LIN 
OC
M
CC
Control cells
DNA-PKcs
KD cl.1
(176 days in culture)
6h after UVC
(10J/m2)
6h after γ rays
(6Gy)
DAPI DNA-PKcs DAPI DNA-PKcs
Figure 3. Functional analysis of NHEJ-deﬁcient HeLa cells. Protein contents were analyzed (A) by immunocytochemical staining (DNA PKcs
KD
cells at day 176 after UVC or g ray irradiation) or (B) by western blotting. 1: Control (pBD650); 2: DNA PKcs
KD cl.1 (pBD743; day 94);
3: XRCC4
KD cl.9 (pBD694; day 94). (C) NHEJ activities were measured using an in vitro NHEJ assay. Agarose gel separation of NHEJ products
was followed by Southern blotting. Reaction products are marked on the right side: M: linear multimers (inter-molecular joining);
OC: open circles (intra-molecular joining); LIN: input linear substrate; CC: covalently closed circles (intra-molecular joining). 1: Control
(pBD650); 2: XRCC4
KD cl.9 (pBD694; day 75). 3: DNA PKcs
KD cl.1 (pBD743; day 75); 4: Control (pBD650); 5: KIN17
KD cl.6 (pBD674; day 81).
6: KIN17
KD cl.12 (pBD674; day 81).
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essential to understand the role of the MRN complex
in the NHEJ and HR pathways. MRE11, Rad50 and
NBS1 are essential genes in vertebrates, which limits
experimental work. Experiments are usually performed
with cells from patients displaying hypomorphic
mutations in either MRE11 (ATLD disease) or NBS1
(NBS syndrome). Recently, one patient with two germline
mutations in RAD50 has been identiﬁed (for review
see 41). For instance, most human NBS cells express an
NH2-terminally truncated Nbs1 protein that contains
an intact Mre11-binding domain (for review see 42).
The latter cells may maintain several biological activities
associated with the MRN complex. In mouse models,
the assessment of MRN functions has also been hampered
by the lethal phenotype of null Mre11, Rad50
and Nbs1 mutants in cultured cells and in vivo
(for review see 43). Only mouse models carrying Rad50S
alleles or mimicking the mutations identiﬁed in human
NBS and A-TLD patients have been characterized
(for review see 44).
I have isolated stable knock-down HeLa clones for the
three components of the MRN complex. In a HeLa
genetic background, all of my Rad50
KD clones exhibited a
very low Rad50 protein level, even 6, 45, 69, 76, 120 or 149
days after transfection, with impressive stability over time
(Figure 4). Hence, the reduced Rad50 protein level did not
signiﬁcantly impair cell growth. Interestingly, in all
experiments performed, the lowered Rad50 protein level
in Rad50
KD clones triggered a marked fall in both Mre11
and Nbs1 protein levels. MRE11 gene silencing induced
a severe decrease in the protein level of the two other
components of the MRN complex (Rad50 and Nbs1).
In contrast, the nearly undetectable level of the Nbs1
Figure 4. Short- and long-term gene silencing for MRN components. (A and B) 45, 69 and 76 days after transfection, Rad50
KD HeLa clones were
analyzed by immunocytochemical staining (magniﬁcation  315) or western blot. 1: Control (pBD650; day 189); 2: XPC
KD cl. 21 (pBD634; day 376);
3: XPA
KD clone 6 (pBD695; day 436); 4: XRCC4
KD clone 9 (pBD694; day 107); 5: Control (pBD650; day 31); 6: Rad50
KD clone 1 (pBD872; day 76);
7: Rad50
KD clone 1 (day 45); 8: Rad50
KD clone 2 (day 45); 9: Rad50
KD clone 3 (day 45); 10: Rad50
KD clone 4 (day 45); 11: Rad50
KD clone 5
(day 45). (C) Transient gene silencing: 6 days after transfection, MRE11
KD (two pEBVsiRNA plasmids), Rad50
KD (one plasmid) and NBS1
KD (two
plasmids) cell populations were analyzed by western blot. 1: Control (pBD650; day 6); 2: MRE11
KD (pBD930; day 6); 3: MRE11
KD (pBD931;
day 6); 4: NBS1
KD (pBD932; day 6); 5: NBS1
KD (pBD934; day 6); 6: ATM
KD (pBD935; day 6); 7: ATM
KD (pBD936; day 6); 8: ATM
KD (pBD937;
day 6); 9: PARG
KD (pBD812; day 6); 10: Rad50
KD (pBD872; day 6); 11: Control (pBD650; day 6); 12: Rad50
KD (day 120). (D) Long-term gene
silencing: Clones were picked up from cell populations described in the panel ‘C’ and propagated for several months in culture. 1: Control (pBD650;
day 238); 2: MRE11
KD cell population (pBD930; day 33); 3: MRE11
KD clone 32 (pBD930; day 132); 4: Rad50
KD clone 1 (pBD872; day 149);
5: NBS1
KD clone 11 (pBD932; day 172); 6: DNA PKcs
KD clone 1 (pBD743; day 391); 7: Ligase III
KD clone 11 (pBD941; day 180).
Nucleic Acids Research, 2007, Vol. 35, No. 11 3541protein in NBS1
KD cells did not induce any change in
Mre11 or Rad50 protein levels. This result was observed
with diﬀerent pEBVsiRNA vectors per gene and in either
short- or very long-term gene silencing experiments
(Figure 4C and D).
This observation suggests that the trimeric
complex MRN supports diﬀerent interactions between
each building block. Rad50 and Mre11 are essential for
the maintenance and stability of the MRN complex,
certainly in the vicinity of DSBs. The loss of either Rad50
or Mre11 triggers destabilization of the whole MRN
complex and the disappearance of the other components.
This was already observed in a patient exhibiting a
truncated mutation in the MRE11 gene associated with
reduced expression of three members of the MRN (45).
Interestingly, the loss of Nbs1 did not interfere with the
stability of either Rad50 or Mre11 proteins, as previously
mentioned with mouse models (for review see 43). These
compelling ﬁndings show that my stable knock-down cell
model has the hallmarks of MRN stability.
Othersensor/transducer proteins
Besides the MRN complex, I targeted other essential
proteins involved in the pathway signaling the presence of
DNA damage, such as the nuclear protein kinases
ataxia telangiectasia mutated (ATM) and ataxia
telangiectasia- and Rad3-related (ATR). ATM and ATR
belong to a conserved family of proteins termed the
‘phosphatidylinositol 3-kinase-like protein kinases’
(PIKKs). PIKKs are conserved from yeast to mammals,
and respond to various stresses by phosphorylating
substrates in the appropriate pathways. The chief
transducer of the DSB signal is ATM (for review
see 46). Another member of this family of kinases is
DNA-PKcs, which has been described above for its gene
silencing. Cells from AT patients (or ATM-nullizygous
mice) are sensitive to ionizing radiation and other agents
that induce DSBs. AT cells fail to activate the IR-induced
G1/S or G2/M checkpoints, and exhibit radioresistant
DNA synthesis, which is indicative of an impaired S-phase
checkpoint (for review see 47). ATR mediates responses to
a broad spectrum of genotoxic stimuli, including DNA
replication inhibitors (e.g. hydroxyurea), UV radiation,
IR and agents such as cis-platinum that induce DNA
interstrand cross-links.
I am currently assessing loss-of-function in ATM
KD
and ATR
KD clones. In my ATM
KD cells (clone BD935/12;
70 days after transfection), there was no appearance of
phosphorylated ATM
Ser-1981 protein after induction of
DNA damage, and, consequently, p53
Ser-15 protein was
absent (J. Bouley, personal communication). Interestingly,
phosphorylation of p53
Ser-15 is necessary for an
IR-induced G1/S arrest via transcriptional induction of
the cyclin-dependent kinase inhibitor p21 (47). ATM gene
silencing did not signiﬁcantly aﬀect HeLa cell growth,
even after several months of culture. In contrast, ATR
KD
cells displayed an elevated rate of spontaneous cell death.
This was in agreement with previous reports showing
that while ATM /  mice are viable, ATR-deﬁcient mice
die early during embryogenesis. Similarly, conditional
knock-out of ATR gene function in human cells leads to a
loss of cellular viability.
Interconnecting DNA repairprocesses
In an eﬀort to reveal the interconnecting features of DNA
repair pathways, I treated my stable clones with genotoxic
agents that inﬂict major damage on DNA, triggering
defects in the cell cycle progression. I postulated that
defects in a speciﬁc DNA repair pathway could be easily
and rapidly assessed by means of ﬂow cytometry. I have
already applied this method to XPA
KD and XPC
KD cells
(25). I used as genotoxic agents UVC, g rays or etoposide
(VP16), for the following reasons: (i) UVC-induced
DNA damage blocks DNA replication and transcription,
(ii) g rays induce DSBs, which are a major threat to
genomic stability and (iii) etoposide is a ‘topoisomerase II
(topo II) poison’, which converts topo II into a
DNA-damaging enzyme by disrupting the cleavage-
religation equilibrium; VP16 induces accumulation
of DSBs, activation of DNA damage sensors, cell
cycle arrest, and initiation of apoptosis or repair
(for review see 48).
All of my stable clones were cultivated, treated and
analyzed using the same procedure at least three times.
Brieﬂy, cells were treated with UVC (10J/m
2), g rays
(6Gy) or etoposide (25mM for 1.5h in the culture
medium). Twenty-four hours later, cells were trypsinized,
ﬁxed with EtOH (70%), and stored at þ48C before ﬂow
cytometry analysis. Not all doses used induced lethality in
control cells at the time of the analysis. Only adherent cells
were analyzed by means of ﬂow cytometry. Here, I show
some of these results. It was noteworthy that I observed
no marked diﬀerences in cell cycle progression in response
to genotoxic insults as a function of the age of the cells
in culture. Afterwards, data from ﬂow cytometry
analyses were constantly checked with classical clonogenic
cell survival assays. In this manner, I could assess
the sensitivity of my clones to both low and high
doses of genotoxic agents after a short or long period in
culture.
The presence of pEBV plasmids in HeLa cells for
several months did not modify cell behavior toward
genotoxic insults. Only a slight increase in the percentage
of cells in G2–M phase after ionizing radiation was
observed in control BD650 cells (21%), in comparison
with mock transfected HeLa cells (13%), which was
certainly due to the presence of hygromycin B.
UVC irradiation. UVC irradiation (10J/m
2)o f
NER-proﬁcient cells (HeLa cells or control BD650 cells)
induces strong G2–M phase arrest, suggesting that UVC
lesions are removed without hampering progression of
DNA replication. However, the high UVC dose used here
leads to the accumulation of damaged cells in G2 phase
(Figure 5A).
As expected, highly UVC-sensitive XPA
KD and XPC
KD
cells were arrested in early and middle S phase, showing
that remaining UVC lesions block DNA replication.
We have previously reported that UVC lesions were
not removed in our NER-deﬁcient cells, which was a
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Figure 5. (A) Cell cycle progression of stable knock-down HeLa clones after UVC (10J/m
2), g rays (6Gy) or etoposide treatment (VP16; 25mM for 1.5h): GG-NER and TC-NER pathways.
Exponentially growing cells were treated and 24h later adherent cells were collected, washed and ﬁxed in 75% ethanol at 48C for at least 24h. Cells were stained with propidium iodide (4mg/ml)
in the presence of RNase (10mg/ml) for at least 30min. Stained cells were analyzed on a FACScalibur (Becton Dickinson) using CellQuest software. Here,  10000 cells gated as single cells using
FL2A/FL2W scatter were analyzed. Each clone was analyzed at least three times. Long-term HeLa clones: Control (BD650, day115), XPC
KD (BD634/21; day 333), hHR23A
KD (BD805/7;
day 158), hHR23B
KD (BD804/9; day 191), XPA
KD (BD695/6; day 422). Arrows indicate a striking point highlighting intolerance to DNA damage. (B) NHEJ and HR pathways. Long-term
HeLa clones: DNAPKcs
KD (BD743/1; day 321), XRCC4
KD (BD694/9; day 235), LigIV
KD (BD940/3; day 103), LigIII
KD (BD941/11; day 82), Rad51
KD (BD864/2; day 107), Rad54
KD (BD912/5;
day 148). (C) Signaling pathways Long-term HeLa clones: MRE11
KD (BD930/32; day 61), Rad50
KD (BD872/1; day 158), NBS1
KD (BD932/11; day 108), ATM
KD (BD935/12; day 111), ATR
KD
(BD962/9; day 56).
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5typical feature of XP cells. In our previous study, we
characterized the XP phenotype of these knock-down
clones (25). Strikingly, while hHR23A
KD cells were not
blocked in S phase after UVC irradiation, many
hHR23B
KD cells were hindered in getting out of S phase
(Figure 5A). This suggested the presence of unrepaired
UVC-induced DNA damage in hHR23B
KD cells.
Therefore, hHR23B
KD cells seemed to behave like XP
cells. This was conﬁrmed by clonogenic survival assays,
where hHR23B
KD cells displayed a signiﬁcant sensitivity
to UVC, in contrast to hHR23A
KD cells, which strongly
tolerated UVC irradiation (Figure 6). This also suggested
that hHR23A and hHR23B displayed diverse biological
functions in humans. In contrast, mHR23A and mHR23B
appeared to have redundant roles in NER. Interestingly,
inactivation of both genes caused embryonic lethality, but
was compatible with cellular viability (49).
UVC-induced stalled replication could trigger an early
commitment to recombination repair pathways because at
later times after treatment arrested forks are degraded into
double-strand breaks (50). This alternative pathway was
reinforced when the p53 protein was inactivated, as
observed in HeLa cells, where the HPV18-E6 protein
may degrade a part of the newly synthesized p53 protein.
As a consequence, I expected to observe an impaired
cellular response to UVC in some recombination repair-
deﬁcient cells. XRCC4
KD and Lig IV
KD on the one hand,
and Rad51
KD cells on the other, seemed to interfere with
the response to UVC-induced DNA damage (Figure 5B).
This was conﬁrmed by clonogenic cell survival assays
(Figure 6). Hence, in a HeLa genetic background,
XRCC4, Lig IV and Rad51 could be essential partners
or limiting factors or both in the commitment of
DNA repair processes after UVC irradiation. These
observations have to be veriﬁed in other cell lines. In
contrast, this relationship between NER and DSBR
pathways seemed to be independent of DNA PKcs.
Since the MRN complex plays an essential role at
sites of blocked replication, it was expected that
MRN-deﬁcient cells would encounter major diﬃculties
after UVC irradiation. MRE11
KD cells, but not Rad50
KD
and NBS1
KD ones, displayed an impaired response to high
doses of UVC irradiation, since many cells remained
stalled in S phase 24h after 10J/m
2 irradiation, as did
XP cells (Figure 5C). However, survival assays revealed
that all MRN-deﬁcient cells (MRE11
KD, Rad50
KD
and NBS1
KD) displayed enhanced sensitivity to UVC
(Figure 6).
NHEJ deficient cells
NER & BER deficient cells Deficient cells in signaling pathways
HR deficient cells
Figure 6. Clonogenic cell survival assays after UVC (4J/m
2), g rays (1Gy) or etoposide treatment (VP16; 1mM for 1.5h). Established long-term
clones were seeded at 500 cells per 6-cm diameter-dish 24h before treatment. Here,  14 days later, cells were ﬁxed and stained. Each point represents
the mean of two independent experiments; each experiment represents three culture dishes per point. SD are indicated. Age of cells at the time of the
last clonogenic cell survival assay: Control (pBD650; day 238); XPC
KD cell cl.21(day 456); hHR23A
KD cl.7 (day 236); hHR23B
KD cl.9 (day 272);
DNA PKcs
KD cl. 1 (day 365); XRCC4
KD cl.9 (day 205); Ligase IV
KD cl.3 (day 176); Ligase III
KD cl.11 (day 178); Rad51
KD cl.2 (day 193); Rad54
KD
cl.5 (day 322); MRE11
KD cl.32 (day 177); Rad50
KD cl.1 (day 175); NBS1
KD cl.11 (day 176); ATM
KD cl.12 (day 302); ATR
KD cl.9 (day 196); Ogg1
KD
cl.27 (day 232). Arrows indicate a striking point highlighting intolerance to DNA damage.
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KD cells failed to elicit impaired progression
of cells in the cell cycle after UVC irradiation, ATR
KD
cells exhibited great intolerance to UVC-induced DNA
damage (Figure 5C). Survival assays reinforced this
observation by showing that ATR
KD cells were very
sensitive to UVC (Figure 6). More generally, major
growth disadvantages and elevated spontaneous cell
death were observed in ATR
KD HeLa cells in comparison
with ATM
KD ones.
g Ray irradiation. Ionizing radiation triggered a slight
G1 phase arrest, with moderate G2 phase blockage in
HeLa cells (Figure 5A). DNA-PKcs
KD, XRCC4
KD and
Lig IV
KD cells, which are deﬁcient in the major DSB-
repair mechanism (NHEJ), displayed marked G2–M
arrest 24h after ionizing radiation (Figure 5B).
In particular, most DNA-PKcs
KD cells were blocked
in G2–M phase 24h after 6Gy. This accumulation of
damaged cells demonstrated intolerance to DSB-inducing
agents in DNA-PKcs
KD, XRCC4
KD and Lig IV
KD cells,
which was conﬁrmed by clonogenic cell survival assays
(Figure 6). A similar result was observed with
Rad51
KD and Rad54
KD cells, most of which were arrested
in G2–M phase (Figure 5B). However, clonogenic cell
survival assays revealed that HR-deﬁcient cells were less
sensitive to ionizing radiation than their NHEJ counter-
parts (Figure 6). In contrast, Lig III
KD cells remained
insensitive to g rays, suggesting a minor role of this
protein in the cellular response to ionizing radiation. It
was noteworthy that the hallmark of Lig III-deﬁcient cells
was enhanced sensitivity to cross-linking agents such as
mitomycin C.
Interestingly, MRE11
KD and NBS1
KD cells elicited
intolerance to a high dose of g rays with marked G2–M
phase blockage (Figure 5C). In clonogenic cell survival
assays, all MRN-deﬁcient cells appeared to be sensitive to
a low dose of g rays (Figure 6).
Strikingly, XPC
KD and hHR23B
KD cells displayed
intolerance to g rays, in contrast to XPA
KD and
hHR23A
KD cells. Interestingly, XPC
KD cells displayed
a moderate sensitivity in survival assays after 1Gy
irradiation (Figure 6). This suggested an indirect role in
a regulatory process. We have recently showed that the
long-term inactivation of the XPC gene induced important
changes in the DNA repair potential by aﬀecting the
NER process, but also other repair pathways. We have
found that XPC deﬁciency in HeLa cells could be
correlated with a decrease in end-joining eﬃciency
(NHEJ DNA repair) (29)
Twenty-four hours after irradiation, ATM
KD and
ATR
KD cells failed to display an impaired cell cycle
progression. However, clonogenic survival assays revealed
that while ATR
KD cells displayed an enhanced sensitivity
after a low dose of ionizing radiation (1Gy) (Figure 6),
ATM
KD cells exhibited a very low radiosensitivity. I could
not rule out that the remaining ATM proteins were
enough to ensure their biological functions.
Etoposide treatment. Cells were treated with etoposide
(VP16) for 1.5h and thereafter culture mediums were
changed to allow recovery after DNA damage. In these
conditions, the treatment was reversible and normal cells
were able to circumvent etoposide-induced DNA
lesions (e.g. DSBs) in order to progress through S phase.
Twenty-four hours after the beginning of the treatment,
most normal cells (mock-treated HeLa cells and BD650)
accumulated in G2–M phase in order to restore their
genomic integrity (Figure 5A).
In NHEJ-deﬁcient cells (DNA-PKcs
KD, XRCC4
KD and
Lig IV), etoposide induced persistent arrest during the
whole S phase, suggesting the presence of unrepaired
(or unrepairable) DNA damage (Figure 5B). This was
conﬁrmed by clonogenic survival assays (Figure 6). In
contrast, Rad51
KD and Rad54
KD cells appeared to be
insensitive to this treatment using my two separate
approaches (Figures 5B and 6). This may suggest that
the NHEJ pathway is the main DNA repair process
required during cell recovery after etoposide treatment
and withdrawal in HeLa cells. No diﬀerence was observed
between control and MRN-deﬁcient cells after etoposide
treatment (Figures 5C and 6). The integrity of the MRN
complex seemed not to be a prerequisite for repair of
etoposide-induced DNA damage.
Interestingly, XPC
KD HeLa cells, but not their XPA
counterparts, displayed intolerance toward etoposide
(Figures 5A and 6). This reproducible result was discussed
in a recent report (29). It appears that beside its canonical
function in the early steps of the NER, the XPC protein
could be essential in the coordination of other recovery
pathways, such as those involved in the repair of
etoposide-induced DNA damage. Hence, my set of cell
lines helps us to emphasize new relationships between
diﬀerent DNA repair processes.
DISCUSSION
Long-term gene silencing opens up new areas in the ﬁeld
of DNA repair. Because evolution has retained highly
sophisticated DNA repair processes that prevent most of
the damage inﬂicted on the genome, it is necessary to
unravel the connections between these pathways in a
genetically homogeneous cell model.
For the ﬁrst time, I present stable clones silenced for
genes acting as sensors/transducers (ATM, ATR, Rad50,
NBS1 and MRE11), or genes of diﬀerent DNA repair
pathways (XPA, XPC, hHR23A, hHR23B, CSA, CSB,
DNA-PKcs, XRCC4, Ligase IV, Rad51, Rad54 or
Ligase III). Other HeLa clones have also been established,
such as PARG
KD (in culture for 113 days) and Ogg1
KD (in
culture for 180 days), which display a spectacular
loss-of-function (G. de Murcia and A. Campalans,
personal communications). I have also constructed and
characterized new eﬃcient pEBVsiRNA plasmids directed
against PARP2, BRCA1, ERCC1, XRCC1, cdc25b
or TRF2 and new clones are now under investigation
(data not shown). All of these clones are being maintained
in culture for further analysis.
My approach is based on new siRNA-expressing
plasmids termed pEBVsiRNA. The intrinsic features of
these plasmids, such as their nuclear retention, their high
stability and their tethering to endogenous chromosomes,
Nucleic Acids Research, 2007, Vol. 35, No. 11 3547greatly improve short- and long-term gene silencing in
human cells (for review see 13). Because the transactivat-
ing function of the oriP/EBNA1 complex is essential for
activation of promoters carried by the plasmid, the reverse
position of the shRNA cartridge related to EBV
components could enhance the long-term transcription
of shRNA sequences (25). This transactivating process
involves EBNA1-induced changes in the chromatin
structure, including DNA looping and nucleosome
destabilization (51). In these conditions, 2 weeks after
transfection (and hygromycin B selection) of pEBVsiRNA
plasmids,  100% of transfected cells were silenced. This
was the case for numerous genes tested, such as XPA,
hHR23A, MRE11, Lig III, Lig IV or Rad50.A sa
consequence, these cell populations are easily propagated
for 41 month and maintained an impressive gene
silencing. Selected clones elicited this marked gene
silencing for an undetermined period in culture, even
after several freeze–thaw cycles. Interestingly, all clones
described here are still being maintained in culture, after
several months or 41 year for my older clones (XPA
KD,
XPC
KD or DNA-PKcs
KD).
I initially developed these new plasmids to compare
short- and long-term gene silencing in DNA repair.
I thought that transient transfection assays could either
amplify or mask the real eﬀects of speciﬁc gene silencing,
due to an overproduction of siRNA in cultured cells,
which could be due to (i) high concentrations of siRNA
duplexes, (ii) very high numbers of copies per cell of an
integrative plasmid or (iii) elevated virus titers. I targeted
genes of the main DNA repair processes (NHEJ, NER,
HR and BER) and of crucial DNA damage signaling
pathways (ATM, ATR and MRN). Stable HeLa clones
were established for all targeted genes. We could then
assess the short- and long-term eﬀects of speciﬁc DNA
repair deﬁciency on diﬀerent biological endpoints, such as
chromosomal and telomeric abnormalities. Experiments
are under way to compare genomic stability and telomere
maintenance as a function of the loss of one speciﬁc DNA
repair pathway (e.g. NHEJ versus HR), after short- and
long-term gene silencing. The high eﬃciency of
pEBVsiRNA vectors in diﬀerent cell lines aﬀords us the
opportunity to rapidly obtain new knock-down clones
that will be stable over time, in particular for certain genes
where to date no mutant lines are available. Most of
these clones display very low or undetectable levels of
the protein of interest, as shown by western blot
or immunocytochemical staining. However, the major
drawback of the RNAi approach is underestimation of the
biological role of a protein, because in theory a residual
amount of the targeted protein remains. This raises
two questions: (i) is the residual protein suﬃcient to
ensure its biological functions, and (ii) can we detect a
loss-of-function in knock-down clones? At present, my
results reveal that knock-down clones exhibited the
expected phenotype with an associated loss-of-function.
For instance, XPA
KD and XPC
KD cells displayed an
impaired UDS with an enhanced UVC sensitivity (25),
XRCC4
KD, LigIV
KD and DNA-PKcs
KD cells failed to
accurately join DNA ends during NHEJ and were highly
sensitive to DSB-generating agents (29). The cellular
response of knock-down clones to diverse genotoxic
injuries seems to be in agreement with the expected
phenotype (Figures 5 and 6). Another point to be
considered is the existence of redundancy in some
functions in mammalian cells. For instance, Rad54B
protein could compensate for the silencing of Rad54 (52).
My data also raise some intriguing and provocative
questions. For instance, (i) do XPC and hHR23B proteins
participate in the cellular response to ionizing radiation?
(ii) does Lig III protein participate in the low-speed
B-NHEJ? (iii) is the NHEJ pathway required for cellular
recovery after etoposide-induced DNA damage? and
(iv) are MRN proteins required during HR or NHEJ or
both? Many other interesting questions emerge from these
data, and the aforementioned stable knock-down clones
aﬀord us the opportunity to answer them.
Because my approach is based on long-term culture,
I cannot exclude the possibility that suppression of gene
expression over a long period may provoke compensatory
cellular responses. In culture, an ‘adaptive period’ may
mask the true biological consequences of speciﬁc gene
silencing. However, this is also true during the multistage
process leading to tumorigenesis, where a normal cell
encounters serial genetic changes, including initiation,
clonal expansion, pre-malignant lesions and malignant
progression, before acquiring a tumoral phenotype.
This adaptive period is also present in other strategies to
switch oﬀ gene expression, as in knock-out mouse models
where clonal cell expansion is required. It is therefore
necessary to characterize the expected phenotype in
knock-down cells during the culture, and also to compare
short- and long-term experiments. In my hands, long-term
silencing of genes of the NER or NHEJ pathways,
mediated by pEBVsiRNA vectors, always gave the
expected phenotypic modiﬁcations.
To conclude, the combination of RNAi technology with
pEBV-derived vectors oﬀers an exceptional opportunity to
rapidly create a set of stable knock-down clones covering
various ﬁelds of genetics. We could mimic human diseases
in a comparable genetic background. This approach may
have several applications in drug screening, and in the
early stages of testing new therapies. Now I have to
develop my approach in other human cells, in particular
normal cells such as stem cells. A recent study reinforces
my strategy by demonstrating that the pEBV vector could
eﬀectively enhance RNA interference eﬃciency in human
stem cells (hES) (53). Abrogation of DNA repair genes
in hES could oﬀer new opportunities, because
genetic modiﬁcations of stem cells have great therapeutic
potential. Another fundamental aspect of this work is the
validation of a speciﬁc siRNA sequence for several weeks
or months in culture. This could ensure unfailing
gene silencing before the beginning of time-consuming
experiments, such as assays on hES.
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